pecified Drug-use Survey of Lotriga Granular Capsules: OCEAN3 (Outcome Prevention on Cardiovascular Events by Antihyperlipidemic Therapy With N3-fatty Acid in Japan)
Phase of Trial: Phase IV
Latest Information Update: 05 Apr 2017
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms OCEAN3
- Sponsors Takeda
- 30 Mar 2017 Planned End Date changed from 1 Sep 2019 to 30 Sep 2019.
- 30 Mar 2017 Planned primary completion date changed from 1 Sep 2019 to 30 Sep 2019.
- 11 Nov 2014 New trial record